MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: A retrospective analysis of medical claims data

    J. Ypinga, N. de Vries, L. Boonen, X. Koolman, M. Munneke, A. Zwinderman, B. Bloem (Tilburg, Netherlands)

    Objective: To study the long-term benefits of specialised physiotherapy using the ParkinsonNet approach in real-world practice. Background: Trials show that specialised allied health interventions are…
  • 2018 International Congress

    Antiglycine Receptor Antibodies and Rapidly Progressive Corticobasal Syndrome

    A. Muñoz González, A. Contreras Chicote, M. Vales Montero, J.M. Velázquez Pérez, B. Dela Casa, E. Luque Buzo, F. Graus, F. Grandas (Madrid, Spain)

    Objective: To describe the first case of non-paraneoplastic autoimmune encephalitis with antiglycine receptor (anti-GlyR) antibodies manifesting as a Corticobasal Syndrome (CBS) and the response to…
  • 2018 International Congress

    The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

    S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)

    Objective: To find out whether a 10 to 14 days group-based multidisciplinary in-patient rehabilitation course for patients with Parkinson´s disease has any long-term effect on…
  • 2018 International Congress

    Clinical features and natural history of pathologically-confirmed corticobasal degeneration: A Japanese validation study of CBD (J-VAC study)

    I. Aiba, T. Shimohata, S. Murayama, K. Hasegawa, Y. Iwasaki, O. Yokota, H. Fujimura, M. Sakai, T. Yokota, I. Yabe, H. Takigawa, K. Sugaya, K. Mori, M. Ito, C. Ishida, M. Kobayashi, Y. Hashizume, T. Ikeuchi, M. Hasegawa, M. Yoshida, T. Komori, K. Wakabayashi, Y. Saito, A. Tokumaru, K. Sakurai, K. Nakashima (Nagoya, Japan)

    Objective: To elucidate the clinical features and natural history of CBD. Background: Recently, various clinical phenotypes of corticobasal degeneration (CBD) have been reported; on the…
  • 2018 International Congress

    Probable MSA presenting initially with urinary retention

    S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

    Objective: We describe 6 cases of probable MSA presenting with urinary retention/incomplete bladder emptying. Background: MSA is a progressive neurodegenerative adult-onset disease whose clinical features…
  • 2018 International Congress

    PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

    J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

    Objective: To evaluate the safety and tolerability of epigallocatechin gallate (EGCG) in high doses and its efficacy to slow down disease progression in patients with…
  • 2018 International Congress

    Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

    D. Swallow, C. Counsell (Aberdeen, United Kingdom)

    Objective: To compare referral and diagnostic time intervals from index symptom to death in PSP/CBD and age-sex matched PD. Background: Misdiagnosis and delayed diagnosis are…
  • 2018 International Congress

    Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

    Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)

    Objective: To compare the cerebrospinal fluid (CSF) levels of 38 cytokines in multiple system atrophy (MSA) patients vs. control and Parkinson’s disease (PD) subjects. Background:…
  • 2018 International Congress

    Movement disorders after stroke in the third Moroccan level hospital, Marrakech

    A. Chahidi, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: The goal of this study is to describe the clinical, paraclinical and evolutive features of patients having suffered a movement disorder in the aftermath…
  • 2018 International Congress

    Musical sonification for the rehabilitation of Parkinsonian dysgraphia: behavioural validation

    L. Véron-Delor, S. Pinto, A. Eusebio, J.L. Velay, J. Danna (Aix-en-Provence, France)

    Objective: To evaluate the effects of musical sonification on handwriting performance in individuals with Parkinson’s disease (PD). Background: Parkinsonian dysgraphia is specifically characterized by the…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley